Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

By Bertucci F.   Finetti P.   Roche H.   Le Doussal J. M.   Marisa L.   Martin A. L.   Lacroix-Triki M.   Blanc-Fournier C.   Jacquemier J.   Peyro-Saint-Paul H.   Viens P.   Sotiriou C.   Birnbaum D.   Penault-Llorca F.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 625-632

Oxford University Press

Access to resources Recommend Favorite

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1046-1054

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant Therapy in Elderly Patients with Early Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 315-325

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy

By                

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1475-1482

Spandidos Publications

Access to resources Recommend Favorite